신라젠은 다음달(4월) 9~12일 영국 옥스퍼드에서 열리는 국제 종양파괴 바이러스 컨퍼런스 2018(International Oncolytic Virus Conference 2018)에서 신장암 환자를 대상으로 펙사벡을 투여한 임상 2상 연구결과를 발표한다고 13일 밝혔다.
뉴스링크
Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
Congratulations @halfpoint! You received a personal award!
Click here to view your Board of Honor
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit
Congratulations @halfpoint! You received a personal award!
You can view your badges on your Steem Board and compare to others on the Steem Ranking
Vote for @Steemitboard as a witness to get one more award and increased upvotes!
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit